Advertisement
Canada markets open in 2 hours 35 minutes

  • S&P/TSX

    22,375.83
    +116.63 (+0.52%)
     

  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     

  • DOW

    39,387.76
    +331.36 (+0.85%)
     

  • CAD/USD

    0.7310
    -0.0001 (-0.01%)
     

  • CRUDE OIL

    79.92
    +0.66 (+0.83%)
     

  • Bitcoin CAD

    86,240.63
    +2,669.46 (+3.19%)
     

  • CMC Crypto 200

    1,304.70
    -53.31 (-3.93%)
     

  • GOLD FUTURES

    2,383.80
    +43.50 (+1.86%)
     

  • RUSSELL 2000

    2,073.63
    +18.49 (+0.90%)
     

  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     

  • NASDAQ futures

    18,297.25
    +82.75 (+0.45%)
     

  • VOLATILITY

    12.78
    +0.09 (+0.71%)
     

  • FTSE

    8,446.97
    +65.62 (+0.78%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6779
    +0.0001 (+0.01%)
     

Should You Buy HealthEquity (HQY) Ahead of Earnings?

Zacks Equity Research
Updated

nvestors are always looking for stocks that are poised to beat at earnings season and HealthEquity, Inc. HQY may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because HealthEquity is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for HQY in this report.

Analysts have very recently bumped up their estimates for HQY, giving the stock a Zacks Earnings ESP of +8.00% heading into earnings season.

HealthEquity, Inc. Price and EPS Surprise

HealthEquity, Inc. Price and EPS Surprise | HealthEquity, Inc. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

ADVERTISEMENT

Given that HQY has a Zacks Rank #3 (Hold) and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for HealthEquity, and that a beat might be in the cards for the upcoming report.

Breaking News: Cryptocurrencies Now Bigger than Visa

The total market cap of all cryptos recently surpassed $700 billion – more than a 3,800% increase in the previous 12 months. They’re now bigger than Morgan Stanley, Goldman Sachs and even Visa! The new asset class may expand even more rapidly in 2018 as new investors continue pouring in and Wall Street becomes increasingly involved.

Zacks’ has just named 4 companies that enable investors to take advantage of the explosive growth of cryptocurrencies via the stock market.

Click here to access these stocks. >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.